EPZM - Epizyme, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.19B
Enterprise Value 3834.06M
Trailing P/E N/A
Forward P/E 1-7.32
PEG Ratio (5 yr expected) 1-0.17
Price/Sales (ttm)40.24
Price/Book (mrq)3.60
Enterprise Value/Revenue 328.19
Enterprise Value/EBITDA 6-6.77

Trading Information

Stock Price History

Beta (3Y Monthly) 2.06
52-Week Change 3-4.64%
S&P500 52-Week Change 36.04%
52 Week High 316.59
52 Week Low 35.14
50-Day Moving Average 313.29
200-Day Moving Average 312.20

Share Statistics

Avg Vol (3 month) 3890.68k
Avg Vol (10 day) 3529.8k
Shares Outstanding 569.48M
Float 76.12M
% Held by Insiders 14.94%
% Held by Institutions 193.24%
Shares Short (Jun 28, 2019) 46.35M
Short Ratio (Jun 28, 2019) 45.23
Short % of Float (Jun 28, 2019) 49.42%
Short % of Shares Outstanding (Jun 28, 2019) 46.99%
Shares Short (prior month May 31, 2019) 43.93M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-419.43%

Management Effectiveness

Return on Assets (ttm)-23.06%
Return on Equity (ttm)-39.67%

Income Statement

Revenue (ttm)29.59M
Revenue Per Share (ttm)0.39
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-84.13M
EBITDA -123.22M
Net Income Avi to Common (ttm)-121.84M
Diluted EPS (ttm)-1.62
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)371.15M
Total Cash Per Share (mrq)4.09
Total Debt (mrq)11.46M
Total Debt/Equity (mrq)3.11
Current Ratio (mrq)12.55
Book Value Per Share (mrq)3.64

Cash Flow Statement

Operating Cash Flow (ttm)-122.82M
Levered Free Cash Flow (ttm)-79.4M